tirzepatide safety breastfeeding on Mounjaro: What New Research Says 📣 New Article Alert! Curious

Since compounded drugs are not FDA approved, the FDA cannot verify their safety, effectiveness or quality before they are marketed

This evidence is further supported in animal models of depression (Tuon et al., 2021)

So, we know that theyre quite safe

A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007

The compounding process follows quality standards and regulatory requirements to ensure the potency and sterility of the final product

MT-2 can be made more effective through the use of environmental tanning, such as the use of sun rays or sun beds